-THE ARGUMENT
Before there's a "plumbing" issue, there's a chemistry problem.
By the time a cardiologist has something to fix — a blocked artery, an event — the body has been signaling for years. Those signals aren't structural. They're metabolic.
THE QUIET CHEMISTRY OF EARLY RISK
Insulin resistance and early glucose dysregulation.
Subtle lipid abnormalities — beyond standard cholesterol.
Visceral fat & inflammation — the "internal" risk.
Genetic patterns that alter how risk develops over time.
These changes often occur long before traditional tests show a problem — especially in South Asians and patients in metabolic transitions.
This is not primarily a cardiology problem at the start. It's a metabolic one. And that is where endocrinology sits.